231 related articles for article (PubMed ID: 31746368)
1. Baicalein inhibits the growth of oral squamous cell carcinoma cells by downregulating the expression of transcription factor Sp1.
Gao Z; Zhang Y; Zhou H; Lv J
Int J Oncol; 2020 Jan; 56(1):273-282. PubMed ID: 31746368
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-1258, regulated by c-Myb, inhibits growth and epithelial-to-mesenchymal transition phenotype via targeting SP1 in oral squamous cell carcinoma.
Zhang H; Jiang S; Guo L; Li X
J Cell Mol Med; 2019 Apr; 23(4):2813-2821. PubMed ID: 30734471
[TBL] [Abstract][Full Text] [Related]
3. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.
Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X
Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517
[TBL] [Abstract][Full Text] [Related]
4. CARD9 downregulation suppresses the growth of oral squamous cell carcinoma by regulating NF-κB.
Ye LJ; Zhou XC; Yin XJ; Shang Y; Xiao Y; Jiang YL; Wen XX
Oral Dis; 2019 Nov; 25(8):1886-1896. PubMed ID: 31306536
[TBL] [Abstract][Full Text] [Related]
5. LncRNA PART1 promotes cell proliferation and inhibits apoptosis of oral squamous cell carcinoma by blocking EZH2 degradation.
Yu Q; Du Y; Wang S; Zheng X
J Biochem; 2021 Sep; 169(6):721-730. PubMed ID: 33725092
[TBL] [Abstract][Full Text] [Related]
6. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
[TBL] [Abstract][Full Text] [Related]
7. Role of transcription factor Sp1 in the 4-O-methylhonokiol-mediated apoptotic effect on oral squamous cancer cells and xenograft.
Cho JH; Lee RH; Jeon YJ; Shin JC; Park SM; Choi NJ; Seo KS; Yoon G; Cho SS; Kim KH; Cho JJ; Cho YS; Kim DH; Hong JT; Lee TH; Park HJ; Jung S; Seo JM; Chen H; Dong Z; Chae JI; Shim JH
Int J Biochem Cell Biol; 2015 Jul; 64():287-97. PubMed ID: 25982202
[TBL] [Abstract][Full Text] [Related]
8. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
[TBL] [Abstract][Full Text] [Related]
9. Icaritin induces mitochondrial apoptosis by up-regulating miR-124 in human oral squamous cell carcinoma cells.
Jin L; Miao J; Liu Y; Li X; Jie Y; Niu Q; Han X
Biomed Pharmacother; 2017 Jan; 85():287-295. PubMed ID: 27889233
[TBL] [Abstract][Full Text] [Related]
10. LncRNA MEG3 suppresses migration and promotes apoptosis by sponging miR-548d-3p to modulate JAK-STAT pathway in oral squamous cell carcinoma.
Tan J; Xiang L; Xu G
IUBMB Life; 2019 Jul; 71(7):882-890. PubMed ID: 30809930
[TBL] [Abstract][Full Text] [Related]
11. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma.
Luo Q; Hu D; Hu S; Yan M; Sun Z; Chen F
BMC Cancer; 2012 Nov; 12():517. PubMed ID: 23151022
[TBL] [Abstract][Full Text] [Related]
13. Combinatorial treatment with Gefitinib and Bay11-7085 sensitizes primary Gefitinib-resistant OSCC cells by influencing the EGFR- NFκB signaling axis.
Sinto MS; Thomas S; Kannan S
Med Oncol; 2021 Aug; 38(9):110. PubMed ID: 34357463
[TBL] [Abstract][Full Text] [Related]
14. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo antitumor effects of chloroquine on oral squamous cell carcinoma.
Jia L; Wang J; Wu T; Wu J; Ling J; Cheng B
Mol Med Rep; 2017 Nov; 16(5):5779-5786. PubMed ID: 28849182
[TBL] [Abstract][Full Text] [Related]
16. Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.
Zhuang Z; Xie N; Hu J; Yu P; Wang C; Hu X; Han X; Hou J; Huang H; Liu X
Oncotarget; 2017 Mar; 8(13):21954-21973. PubMed ID: 28423539
[TBL] [Abstract][Full Text] [Related]
17. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
[TBL] [Abstract][Full Text] [Related]
18. Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis.
Liu R; Peng J; Wang H; Li L; Wen X; Tan Y; Zhang L; Wan H; Chen F; Nie X
Cell Physiol Biochem; 2018; 49(5):1717-1733. PubMed ID: 30231242
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel in combination with cetuximab exerts antitumor effect by suppressing NF-κB activity in human oral squamous cell carcinoma cell lines.
Harada K; Ferdous T; Kobayashi H; Ueyama Y
Int J Oncol; 2014 Dec; 45(6):2439-45. PubMed ID: 25230791
[TBL] [Abstract][Full Text] [Related]
20.
Zhang J; Wu J; Chen Y; Zhang W
Biochem Cell Biol; 2021 Aug; 99(4):424-434. PubMed ID: 34283652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]